A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
Clinical trial NCT07054515 · RECRUITING
Trial details
- NCT number
- NCT07054515
- Sponsor
- Azafaros B.V.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2028-05-14
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.